Announcement PDF BPH Global ASX Announcement | 6 Feb 2026 1 ASX RELEASE 6 February 2026 BPH Global Ltd Executes Binding MoU with Indonesia’s National Research and Innovation Agency (BRIN) Highlights ● BPH Global’s Indonesian subsidiary, PT BPH Global Indonesia, has executed a binding Memorandum of Understanding (MoU) with Badan Riset dan Inovasi Nasional (BRIN), Indonesia’s National Research and Innovation Agency. ● The MoU was executed as part of “BRIN Goes to Industries”, a national initiative designed to accelerate research downstreaming (hilirisasi) and strategic industrial capability. ● PT BPH Global Indonesia was selected by BRIN to execute an MoU alongside a limited group of industry participants, including Garuda Maintenance Facility Aero Asia Tbk and PT Asia Aquatech Indo. ● MoU functions as a general framework agreement, with specific R&D projects to be governed by separate project-specific cooperation agreements. ● Fucoidan extraction technology is expected to be the first R&D project progressed under the MoU, subject to execution of a project-specific agreement. ● BRIN currently holds existing, formally registered background intellectual property in Indonesia relating to fucoidan extraction technology, which enables the extraction of fucoidan for downstream use in anti-ageing and related applications. ● Pursuant to the MoU framework, this background IP may be directly transferred and licensed to BPH Global under agreed licensing terms (Perjanjian Lisensi) to support the development and commercialisation of fucoidan-based anti-ageing products. ● BRIN is also open to co-development R&D with BPH Global to further develop or improve the fucoidan extraction technology and its application in anti-ageing products, with any jointly created IP contemplated to be jointly owned and governed by a separate agreement. ● Fucoidan is a naturally occurring bioactive compound derived from brown seaweed and is widely researched and utilised globally in cosmetic and personal-care formulations, including anti-ageing applications, due to its functional and bioactive properties. ● The MoU has an initial term of three (3) years, with the first implementing agreements contemplated within six (6) months. The Board of BPH Global Ltd (ASX: BP8) (BP8, BPH Global or Company) a leading commercial seaweed supply and export Company, is pleased to advise that its Indonesian operating subsidiary, PT BPH Global Indonesia, has executed a binding Nota Kesepahaman (Memorandum of Understanding / MoU) with Badan Riset dan Inovasi Nasional (BRIN), Indonesia’s National Research and Innovation Agency. Chairman of BPH Global Ltd, Paul Stephenson, commented: “This Memorandum of Understanding with BRIN represents an important milestone for BPH Global. BRIN is Indonesia’s national research and innovation agency, and being selected to enter into a formal collaboration framework alongside a small group of industry participants reflects the alignment of our seaweed strategy with Indonesia’s national research downstreaming objectives. BPH Global ASX Announcement | 6 Feb 2026 2 The MoU provides a structured pathway to access established government-owned technology, progress collaborative R&D and, subject to further agreements, pursue defined commercialisation outcomes. In particular, the potential to license existing fucoidan extraction intellectual property and to work with BRIN on further development of this technology supports our longer-term focus on value-added seaweed derivatives, including applications in anti-ageing products. We view this collaboration as a disciplined, step-by-step engagement with Indonesia’s innovation ecosystem, consistent with our approach to building sustainable, research-backed opportunities in the seaweed sector.” “BRIN Goes to Industries” – National Strategic Context The MoU was signed in Jakarta on Thursday, 5 February 2026 during a formal cooperation signing session hosted by BRIN at the Auditorium Sumitro Djojohadikusumo, B.J. Habibie Building, Central Jakarta. The signing formed part of BRIN’s “BRIN Goes to Industries” program. Signing Ceremony at the Auditorium Sumitro Djojohadikusumo, B.J. Habibie Building, Central Jakarta, 5 February 2026 The BRIN Goes to Industries program is a national initiative directed at accelerating research downstreaming (hilirisasi riset) toward national strategic industrial self-reliance, and brings together government, state-owned enterprises, private industry and research institutions within a structured collaboration framework. The event agenda included addresses by senior BRIN leadership, a formal signing ceremony across multiple cooperation stages, BPH Global ASX Announcement | 6 Feb 2026 3 a press conference, and a Strategic Industry Innovation Dialogue involving Indonesian state-owned enterprises and industry bodies. Selective Industry Participation and Engagement Stages The formal signing session reflected BRIN’s staged engagement and development model, with different legal instruments corresponding to different levels of collaboration maturity. • Framework Collaboration – Memorandum of Understanding (MoU) The MoU category represents the formal entry point into BRIN’s cooperative research and innovation pipeline. Entities selected by BRIN to execute MoUs at the event included: o Garuda Maintenance Facility Aero Asia Tbk ((NYSE-level aviation MRO, part of the Garuda Indonesia Group); o PT Asia Aquatech Indo (a specialised Indonesian company active in the aquaculture/seaweed value chain); and o PT BPH Global Indonesia. The Company notes that participation at the MoU level reflects BRIN’s assessment of alignment with national research down streaming priorities and sector relevance. • Subsequent stages of engagement Subsequent stages of engagement, as reflected in the event agenda, include project execution through cooperation agreements (Perjanjian Kerja Sama) and commercialisation through licence agreements (Perjanjian Lisensi), evidencing BRIN’s structured end-to-end innovation and commercialisation model. Purpose and Scope of the MoU The MoU establishes a cooperation framework to: • act as a guideline for the parties to undertake R&D and innovation activities relating to seaweed-derived products; and • synergise resources and competencies to support the development, utilisation and industrial down streaming of R&D outputs. The scope of collaboration includes research, development, assessment, application, invention and innovation of seaweed-derived products; utilisation of resulting R&D outputs; shared use of facilities and infrastructure (subject to applicable rules); exchange of personnel and experts; human resource capacity building; and other agreed activities consistent with each party’s mandate and applicable laws. Framework Nature of the Agreement The MoU functions as a general framework agreement governing the overall collaboration between the parties. Under this framework: • BRIN acts as a collaborative research partner, not as a contract R&D service provider; and • each specific R&D initiative will be governed by a separate project-specific cooperation agreement, defining objectives, scope, milestones, duration, funding and respective contributions. BPH Global ASX Announcement | 6 Feb 2026 4 Fucoidan Technology – Background IP and First Project Focus BRIN has advised that, with respect to fucoidan extraction technology, BRIN currently holds existing background intellectual property that has been formally registered in Indonesia. Fucoidan is a naturally occurring bioactive compound derived from brown seaweed and is widely researched and utilised globally in cosmetic and personal- care formulations, including anti-ageing applications, due to its functional and bioactive properties. Under the MoU framework: • this background IP may be directly transferred and licensed to BPH Global under agreed licensing terms (Perjanjian Lisensi); and • BRIN is open to undertaking co-development R&D activities with BPH Global to further develop or improve the technology. The Company expects that the extraction of fucoidan from seaweed and its application as a core ingredient in anti- ageing products will be the first R&D project progressed under the MoU, subject to the negotiation and execution of a project-specific cooperation agreement defining scope, milestones, contributions, intellectual property arrangements and commercialisation pathways. Intellectual Property and Commercialisation Key intellectual property principles under the MoU framework include: • background IP remains with the originating party; • new IP generated through jointly conducted R&D is contemplated to be jointly owned, with ownership proportions and management governed by a separate joint IP management agreement; and • where jointly generated IP is commercialised, such commercialisation is intended to occur through licensing arrangements, with BRIN not participating as an equity holder in any commercial entity. Term and Funding The MoU is effective for three (3) years from the date of signing and may be extended by mutual agreement. Costs arising from activities under the MoU are to be borne by each party’s respective budgets and/or other lawful funding sources, subject to applicable regulations. Strategic Rationale The Company views this MoU as a significant step in establishing a structured collaboration with Indonesia’s national innovation agency, providing a clear framework to advance seaweed-derived R&D, validation and defined commercialisation pathways, including access to existing government-owned technology and opportunities for co- development aligned with Indonesia’s national down streaming agenda. BPH Global ASX Announcement | 6 Feb 2026 5 About BRIN Badan Riset dan Inovasi Nasional (BRIN) is Indonesia’s National Research and Innovation Agency and a cabinet-level government institution operating under the President of the Republic of Indonesia. BRIN is responsible for coordinating, conducting and promoting research, development, assessment and application of science and technology across Indonesia. BRIN plays a central role in Indonesia’s research down streaming (hilirisasi) strategy, which seeks to translate publicly funded research into applied technologies and commercially viable outcomes through structured collaboration with industry across priority sectors including marine bioindustry, advanced materials, agriculture and strategic manufacturing. ENDS This release has been approved by the Board of BPH Global Limited. For further information, please visit our website at www.bphglobal.com or contact the Company Secretary on 03 9088 2049. BPH GLOBAL LTD ACN 009 104 330 Suite 303, Level 3 365 Little Collins Street Melbourne VIC 3000